Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system.
Presence of aberrant V<formula>_{H}</formula>6 domains in anti-interferon-γ autoantibodies in multiple sclerosis.
[Pathogenesis of neuromyelitis optica].
[Of worms and men--Administration of helminth products as an innovative approach to treatment of autoimmune diseases].
Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network.
An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device.
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine.
[Retrospective study of clinical features of neuromyelitis optica spectrum disease with connective tissue disease].
Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy.
Novel remyelination strategy for multiple sclerosis in the era of oligodendrocytopathy.
Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus.
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation.
Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and th17 T-helper cell subsets and is a direct stat target gene.
The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis.
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
A high throughput flow gradient LC-MS/MS method for simultaneous determination of fingolimod, fampridine and prednisone in rat plasma, application to in vivo perfusion study.
Clinical data and regulatory issues of biosimilar products.
Patients' perspectives on quality of mental health care for people with MS.
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab.
Autobiographical memory in multiple sclerosis patients: Assessment and cognitive facilitation.
Cerebral white matter disease in patients with malignancy: pml versus toxic leucoencephalopathy due to chemotherapy.
The incidence and prevalence of multiple sclerosis in nova scotia, Canada.
Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study.
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.

Pages